Three investment funds with holdings in Spanish drugmaker Grifols have teamed up to ask to fill a vacant seat on the company’s board, they said in a statement late on Thursday.
They said Grifols, which produces plasma-based medicines, had “an attractive growth profile” and its shares were undervalued and they wanted to make sure any takeover offer would include “a price that is fair for all shareholders”.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer: